IMS Health Holdings Inc

IMS Health — Q2 2015 Earnings Presentation

18 slides from IMS Health's earnings presentation, Jul 31, 2015

  1. Slide 1: IMS Health Q2 2015 Earnings Call

    IMS Health Q2 2015 Earnings Call July 31, 2015 0

  2. Slide 2: Legal

    Legal This presentation should be viewed in conjunction with IMS Health’s Q2 2015 earnings call Safe Harbor Statement This presentation Thi t ti includes i l d “forward-looking “f d l ki statements”, t t t ” including i l di statements t t t regarding di future f t fi financial i l and d operating t

  3. Slide 3: 2nd Quarter Results

    2nd Quarter Results $M Revenue Adjusted EBITDA +24.6% +9.5% @ CFx @ CFx $742 $662 $220 $226 Q2 2015 Q2 2014 Q2 2015 Q2 2014 Note: Dollars are actual foreign exchange rates. CFx is constant currency. EBITDA is “Adjusted EBITDA” as calculated in the appendix of this presentation 2 IMS Health Confident

  4. Slide 4: 2nd Quarter Offering Revenue

    2nd Quarter Offering Revenue Offering 2nd Quarter Versus Prior Year Constant $M 2015 2014 Reported Currency Information $374 $386 9.4% (3.2%) Technology Services $368 $276 45.6% 33.3% Total $742 $662 24.6% 12.0% Note: Dollars are actual foreign exchange rates 3 IMS Health Confidential

  5. Slide 5: 2nd Quarter Geographic Revenue

    2nd Quarter Geographic Revenue Geography 2nd Quarter Versus Prior Year Constant $M 2015 2014 Reported Currency Developed Markets $612 $543 23.5% 12.7% Emerging Markets $130 $119 29.4% 8.8% Total $742 $662 24.6% 12.0% Note: Dollars are actual foreign exchange rates 4 IMS Health Confidential

  6. Slide 6: 2nd Quarter EBITDA

    2nd Quarter EBITDA 2nd Quarter Versus Prior Year Constant $M 2015 2014 Reported Currency Adjusted EBITDA (1) $220 $226 9.5% (2.3%) Adjusted EBITDA margin 29.7% 34.0% (410) bps (441) bps Note: Dollars are actual foreign exchange rates (1) See reconciliations of non-GAAP items in appendix 5 IMS Health

  7. Slide 7: 2nd Quarter P&L

    2nd Quarter P&L At reported FX rates $M (except per share data) 2015 2014 Net Income / (Loss) $47 $(220) Diluted Earnings / (Loss) per Share $0.14 $(0.67) Adjusted Net Income (1) $125 $134 Adjusted Diluted Earnings per Share (1) $0.37 $0.39 (1) See reconciliations of non-GAAP items in appendix 6 IMS

  8. Slide 8: Year-to-date Revenue

    Year-to-date Revenue Offering Year-to-date Versus Prior Year Constant $M 2015 2014 Reported Currency Information $728 $767 6.2% (5.1%) Technology Services $646 $540 29 5% 29.5% 19 6% 19.6% Total $1,374 $1,307 15.9% 5.1% Geography Year-to-date Versus Prior Year Developed Markets $1,134 $1,075 14.9% 5

  9. Slide 9: Year-to-date P&L

    Year-to-date P&L $M (except per share data) 2015 2014 Adjusted EBITDA (1) $436 $443 Adjusted EBITDA margin 31.7% 33.9% Net Income / (Loss) $345 $(244) Diluted Earnings / (Loss) per Share $1 01 $1.01 $(0 80) $(0.80) Adjusted Net Income (1) $261 $204 Adjusted Diluted EPS (1) $0.76 $0.65 (1) See reconc

  10. Slide 10: 2nd Quarter Balance Sheet Items & Metrics

    2nd Quarter Balance Sheet Items & Metrics $M 2015 2014 Cash & Cash Equivalents q $348 $390 (1) Principal Balance of Debt (2) $4,214 $3,816 (1) Net Debt $3,866 $3,426 (1) Gross Leverage Ratio 4.8x 4.3x (1) Net Cash (Used in) Provided by Operating Activities $186 $(126) Capital Expenditures and Additi

  11. Slide 11: 2015 Guidance

    2015 Guidance Q3 2015 Full-Year 2015 Revenue Growth Constant Currency 23 - 24% 19 - 20% Reported (1) 13 - 14% ~10% Adjusted EBITDA Growth Constant Currency 7.5% - 8.5% 13 - 14% Reported (1) (2%) - (3%) ~4% Adjusted Net Income Growth Constant Currency (1%) - (2%) 20 - 23% Reported (1) (12%) - (14%) 8

  12. Slide 12: Q&A

    Q&A 11

  13. Slide 13: Appendix: Non-GAAP Financial Measures

    Appendix: A di Non-GAAP N GAAP Financial Measures 12

  14. Slide 14: Net Income to Adjusted EBITDA

    Net Income to Adjusted EBITDA Three Months Ended Six Months Ended June 30, June 30, (in millions) 2015 2014 2015 2014 Net Income (Loss) $ 47 $ (220) $ 345 $ (244) Provision for / (Benefit from) income taxes 13 (139) (227) (152) Other (income) loss, net (6) 271 (10) 288 Interest expense 43 49 80 138

  15. Slide 15: Net Income to Adjusted Net Income & Per Share Data

    Net Income to Adjusted Net Income & Per Share Data Three Months Ended Six Months Ended June 30, June 30, (in millions, except per share data) 2015 2014 2015 2014 Net Income (Loss) $ 47 $ (220) $ 345 $ (244) Provision for / (Benefit from) income taxes 13 (139) (227) (152) Amortization associated with

  16. Slide 16: Unlevered Free Cash Flow

    Unlevered Free Cash Flow Three Months Ended Six Months Ended June 30, June 30, (in millions) 2015 2014 2015 2014 Net Cash Provided by (Used in) Operating Activities $ 186 $ (126) $ 215 $ (229) Capital expenditures (16) (12) (25) (45) Additions to computer software (30) (23) (53) (44) Free Cash Flow

  17. Slide 17: Gross Leverage Ratio

    Gross Leverage Ratio (in millions) Gross Debt as of June 30, 2015 $ 4,214 Adjusted EBITDA for the year ended December 31, 2014 878 Less: Adjusted EBITDA for the six months ended June 30, 2014 (443) Add: Adjusted EBITDA for the six months ended June 30, 2015 436 Adj t d EBITDA for Adjusted f the th t

  18. Slide 18: Non-GAAP Adjustments By Income Statement Line Items

    Non-GAAP Adjustments By Income Statement Line Items Three Months Ended Six Months Ended June 30, June 30, (in millions) 2015 2014 2015 2014 Non-GAAP adjustments included in: Operating costs of information, exclusive of depreciation and amortization 1 13 2 17 Direct and incremental costs of technolog

IMS Health — Q2 2015 Earnings Presentation on 6ix